Genetic variation enhances cancer drug sensitivity in specific patient groups, study shows By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups. This is shown in a study by Uppsala University, published in the journal eBiomedicine. The findings suggest a potential for more individually tailored and more effective cancer therapies.
https://medicalxpress.com/news..../2024-11-genetic-var